PIPR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Piper Sandler (PIPR) is not a strong buy right now for a beginner long-term investor, despite a reasonable pre-market price near support and some positive analyst support. The technical trend is still bearish, there is no bullish proprietary signal, insider selling has increased, and options flow looks mixed-to-bearish. For an impatient investor who does not want to wait for a better entry, this is still a hold rather than a buy.
PIPR is trading pre-market at 79.23, just below the pivot level of 79.682 and above S1 at 77.419. The short-term technical picture is weak: MACD histogram is negative and expanding, RSI_6 at 40.713 is neutral but leaning soft, and moving averages are bearish with SMA_200 > SMA_20 > SMA_5. That indicates the stock is still in a downtrend or recovery phase rather than a confirmed uptrend. The stock trend model suggests modest near-term upside, but not enough to override the bearish technical structure.
Analyst sentiment remains supportive overall: Goldman Sachs kept a Buy rating and raised the price target to $97 from $88, while Northland upgraded the stock to Outperform with a $350 target earlier in the period. Goldman also cited improving M&A and debt capital markets activity. The stock trend model points to potential upside over the next week and month, and the pre-market price is near the pivot zone, which could attract buyers if momentum improves. There is also no negative news in the past week.
There has been no recent news-driven catalyst in the last week, so momentum lacks a fresh trigger. Insider activity is a clear negative: insiders have been selling, and the selling amount increased 285.82% over the last month. Hedge funds are neutral with no significant trend. The technical setup is bearish, and options volume is heavily put-skewed, which suggests traders are positioning defensively.
No usable latest-quarter financial snapshot was provided, so quarterly revenue or earnings growth cannot be assessed directly. As a result, there is no confirmed financial acceleration or slowdown to support a buy decision. The available data is insufficient to make a strong fundamental-growth case.
Analyst sentiment is constructive but mixed in target revisions. Goldman Sachs repeatedly maintained a Buy rating, recently raising the target to $97 from $88, though it had earlier cut the target from $98 and then from much higher levels as sector estimates were adjusted. Northland upgraded the stock to Outperform with a $350 target, citing an inflection point in advisory business and a stronger M&A pipeline. Wall Street pros see upside from M&A recovery and Piper's acquisition strategy, while cons include slower recent deal growth, multiple compression, and sensitivity to macro/geopolitical uncertainty. Overall analyst opinion is positive, but the target revisions show some softening in conviction.
